Search results

Innovative software tool developed at ANSTO used at power stations to help maintain plant components and improve the efficiency of operations.

ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.

With more than 50 years of experience in monitoring natural and anthropogenic radionuclides in the environment, ANSTO can provide the crucial data and insights you need to assist with the planning and risk management associated with oil and gas decommissioning.

ANSTO is committed to monitoring its environmental performance and providing the community with accurate information about it. We also publish live meteorological data from our 49m Lucas Heights weather tower every 15 minutes.

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

New material shows enhanced conductivity for solid oxide fuel cells used in satellites, spacecraft, transport vehicles and as power source

Experiments at the Synchrotron enable researchers to produce a 3D structure of a molecular scaffold with role in cancer

Melbourne researchers have used the Australian Synchrotron to produce structure of molecule known to play a critical role in the development and spread of aggressive cancer.

A “super” receptor that helps kill HIV infected cells identified.

Sample environments, Data Analysis, Mail-in Services.

Just under 250 schools in Australia and one school in Malaysia will participate in a series of science-based competitions during to coincide with National Science Week in 2024.

You are invited to submit to the various awards

Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.